Trough concentration and ABCG2 polymorphism are better to predict imatinib response in chronic myeloid leukemia: a meta-analysis

Pharmacogenomics January 2017, Vol. 18, No. 1, Pages 35-56.

Source: Future Medicine: Pharmacogenomics - December 18, 2016 Category: Genetics & Stem Cells Authors: Zhi-Ping Jiang Xie-Lan Zhao Naoto Takahashi Sabrina Angelini Biswajit Dubashi Li Sun Ping Xu Source Type: research